Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Stem Cell Research

  Free Subscription


Articles published in Bone Marrow Transplant

Retrieve available abstracts of 252 articles:
HTML format
Text format



Single Articles


    March 2017
  1. BRESTERS D, Wanders DC, Louwerens M, Ball LM, et al
    Permanent diffuse alopecia after haematopoietic stem cell transplantation in childhood.
    Bone Marrow Transplant. 2017 Mar 20. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  2. OH A, Patel PR, Aardsma N, Mehendale SR, et al
    Non-myeloablative allogeneic stem cell transplant with post-transplant cyclophosphamide cures the first adult patient with congenital dyserythropoietic anemia.
    Bone Marrow Transplant. 2017 Mar 20. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  3. KAWAJIRI A, Fuji S, Tanaka Y, Kono C, et al
    Clinical impact of hyperglycemia on days 0-7 after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2017 Mar 20. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  4. BURMAN J, Kirgizov K, Carlson K, Badoglio M, et al
    Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transp
    Bone Marrow Transplant. 2017 Mar 20. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  5. LUSSANA F, Di Ianni M, Rambaldi A
    Tregs: hype or hope for allogeneic hematopoietic stem cell transplantation?
    Bone Marrow Transplant. 2017 Mar 20. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  6. SAAD A, Lamb LS
    Ex vivo T-cell depletion in allogeneic hematopoietic stem cell transplant: past, present and future.
    Bone Marrow Transplant. 2017 Mar 20. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  7. MORGENSTERN DA, Gray P, Prudhoe A, Watts M, et al
    Developing quality assurance for pediatric autologous stem cell transplants in England: results of a 3-year national audit of activity and engraftment by treatment centre.
    Bone Marrow Transplant. 2017 Mar 13. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  8. DOTOLI GM, De Santis GC, Orellana MD, de Lima Prata K, et al
    Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III/IV after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Mar 13. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  9. CETIN M, Akyol G, Gonen ZB, Keklik M, et al
    Additional infusions of mesenchymal stem cells improve response rate in multidrug-resistant GvHD patients.
    Bone Marrow Transplant. 2017 Mar 13. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  10. HO C, Zacharin M
    Fertility preservation in an adolescent boy: inducing puberty and spermatogenesis prior to elective, non-urgent bone marrow transplantation.
    Bone Marrow Transplant. 2017 Mar 13. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  11. PASSWEG JR, Baldomero H, Bader P, Bonini C, et al
    Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report.
    Bone Marrow Transplant. 2017 Mar 13. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  12. DALLE JH, Lucchini G, Balduzzi A, Ifversen M, et al
    State-of-the-art fertility preservation in children and adolescents undergoing haematopoietic stem cell transplantation: a report on the expert meeting of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transp
    Bone Marrow Transplant. 2017 Mar 13. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  13. NATORI Y, Humar A, Lipton J, Kim DD, et al
    A pilot randomized trial of adjuvanted influenza vaccine in adult allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2017 Mar 6. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  14. COOLING L, Sankar A, Mody R, Yanik G, et al
    A severe umbilical cord stem cell infusion reaction due to dextran in an atopic pediatric patient.
    Bone Marrow Transplant. 2017 Mar 6. doi: 10.1038/bmt.2017.
    PubMed     Text format    


    February 2017
  15. O'HARE P, Lucchini G, Cummins M, Veys P, et al
    Allogeneic stem cell transplantation for refractory acute myeloid leukemia in pediatric patients: the UK experience.
    Bone Marrow Transplant. 2017 Feb 20. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  16. LUM SH, Miller WP, Jones S, Poulton K, et al
    Changes in the incidence, patterns and outcomes of graft failure following hematopoietic stem cell transplantation for Hurler syndrome.
    Bone Marrow Transplant. 2017 Feb 20. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  17. IGLESIAS L, Perera MM, Torres-Minana L, Pena-Lopez MJ, et al
    CMV viral load in bronchoalveolar lavage for diagnosis of pneumonia in allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Feb 20. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available


  18. BOURLON C, Alamoudi S, Kumar D, Viswabandya A, et al
    A short tale of blood, kidney and brain: BK virus encephalitis in an allogeneic stem cell transplant recipient.
    Bone Marrow Transplant. 2017 Feb 20. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  19. BLUM V, Heini AD, Novak U, Taleghani BM, et al
    Hematopoietic stem cell remobilization with vinorelbine and filgrastim in AML.
    Bone Marrow Transplant. 2017 Feb 13. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  20. TANAKA Y, Kurosawa S, Tajima K, Tanaka T, et al
    Increased incidence of oral and gastrointestinal secondary cancer after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Feb 13. doi: 10.1038/bmt.2017.
    PubMed     Text format    


  21. YAMASHITA T, Ikegame K, Kojima H, Tanaka H, et al
    Effective desensitization of donor-specific HLA antibodies using platelet transfusion bearing targeted HLA in a case of HLA-mismatched allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2017 Feb 6. doi: 10.1038/bmt.2017.
    PubMed     Text format    


    January 2017
  22. BERRO M, Palau Nagore MV, Rivas MM, Longo P, et al
    Transforming growth factor-beta1 functional polymorphisms in myeloablative sibling hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Jan 30. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  23. LE BRIS Y, Guillaume T, Menard A, Illiaquer M, et al
    Lymphocyte expansion after unrelated cord blood allogeneic stem cell transplantation in adults.
    Bone Marrow Transplant. 2017 Jan 30. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  24. LEON-RODRIGUEZ E, Rivera-Franco MM, Campos-Castro A
    Is day +1 omission of methotrexate associated with higher incidence of acute GvHD in hematopoietic stem cell transplantation?
    Bone Marrow Transplant. 2017 Jan 23. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  25. ROUX C, Tifratene K, Socie G, Galambrun C, et al
    Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the societe Francophone de greffe de moelle et de therapie cellulaire (SFGM-TC).
    Bone Marrow Transplant. 2017 Jan 23. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  26. FUJI S, Maeshima AM, Kim SW, Fukuda T, et al
    Significant nutrient deposition in the liver after allogeneic hematopoietic stem cell transplantation: pathological analysis of 25 autopsy cases.
    Bone Marrow Transplant. 2017 Jan 23. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  27. PUNDOLE X, Cheema HI, Petitto GS, Lopez-Olivo MA, et al
    Prevention and treatment of bone loss and fractures in patients undergoing a hematopoietic stem cell transplant: a systematic review and meta-analysis.
    Bone Marrow Transplant. 2017 Jan 23. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  28. MILLER PD, de Silva TI, Skinner R, Gilleece M, et al
    Routine vaccination practice after adult and paediatric allogeneic haematopoietic stem cell transplant: a survey of UK NHS programmes.
    Bone Marrow Transplant. 2017 Jan 23. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  29. BATTIPAGLIA G, Labopin M, Candoni A, Fanin R, et al
    Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMT.
    Bone Marrow Transplant. 2017 Jan 16. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  30. RADFORD J, McKay P, Malladi R, Johnson R, et al
    Treatment pathways and resource use associated with recurrent Hodgkin lymphoma after autologous stem cell transplantation.
    Bone Marrow Transplant. 2017 Jan 16. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  31. BOUDIN L, Goncalves A, Sabatier R, Moretta J, et al
    Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Jan 16. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  32. SORGE C, Pereboeva L, Westin E, Harris WT, et al
    Pulmonary complications post hematopoietic stem cell transplant in dyskeratosis congenita: analysis of oxidative stress in lung fibroblasts.
    Bone Marrow Transplant. 2017 Jan 16. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  33. GLEZERMAN IG, Devlin S, Maloy M, Bui M, et al
    Long term renal survival in patients undergoing T-Cell depleted versus conventional hematopoietic stem cell transplants.
    Bone Marrow Transplant. 2017 Jan 16. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  34. CAI WZ, Cen JN, Chen J, Chen F, et al
    Major molecular response prior to allogeneic hematopoietic stem cell transplantation predicts better outcome in adult Philadelphia-positive acute lymphoblastic leukemia in first remission.
    Bone Marrow Transplant. 2017 Jan 16. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  35. BAUMGARTNER A, Bargetzi A, Zueger N, Bargetzi M, et al
    Revisiting nutritional support for allogeneic hematologic stem cell transplantation-a systematic review.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  36. GROSSO D, Johnson E, Colombe B, Alpdogan O, et al
    Acquired uniparental disomy in chromosome 6p as a feature of relapse after T-cell replete haploidentical hematopoietic stem cell transplantation using cyclophosphamide tolerization.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  37. PITTMAN C, Hsieh MM, Coles W, Tisdale JF, et al
    Reversal of pre-capillary pulmonary hypertension in a patient with sickle cell anemia who underwent haploidentical peripheral blood stem cell transplantation.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  38. UTRIAINEN P, Vatanen A, Toiviainen-Salo S, Saarinen-Pihkala U, et al
    Skeletal outcome in long-term survivors of childhood high-risk neuroblastoma treated with high-dose therapy and autologous stem cell rescue.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  39. FUJIWARA H, Fuji S, Wake A, Kato K, et al
    Dismal outcome of allogeneic hematopoietic stem cell transplantation for relapsed adult T-cell leukemia/lymphoma, a Japanese nation-wide study.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  40. DULERY R, Nibourel O, Gauthier J, Elsermans V, et al
    Impact of Wilms' tumor 1 expression on outcome of patients undergoing allogeneic stem cell transplantation for AML.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  41. SCHULTZE-FLOREY RE, Tischer S, Kuhnau W, Heim A, et al
    Persistent recipient-derived human adenovirus (HAdV)-specific T cells promote HAdV control after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  42. LIU Z, Zhang Y, Xiao H, Yao Z, et al
    Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  43. GAUTHIER J, Castagna L, Garnier F, Guillaume T, et al
    Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  44. MCDUFFEE E, Aue G, Cook L, Ramos-Delgado C, et al
    Tumor regression concomitant with steroid-refractory GvHD highlights the pitfalls of PD-1 blockade following allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  45. CARRE M, Thiebaut-Bertrand A, Larrat S, Leroy V, et al
    Fatal autochthonous fulminant hepatitis E early after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2017 Jan 9. doi: 10.1038/bmt.2016.
    PubMed     Text format    


    December 2016
  46. BARABAN EG, Hu S, Hui P, Podoltsev N, et al
    Tissue-based chimerism analysis enhances detection of donor-derived neoplasia in allogeneic stem cell transplant patients.
    Bone Marrow Transplant. 2016 Dec 19. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  47. STENEHJEM JS, Smeland KB, Murbraech K, Holte H, et al
    Diffusing capacity impairment is prevalent in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation.
    Bone Marrow Transplant. 2016 Dec 19. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  48. PFEIFFER TM, Rotz SJ, Ryan TD, Hirsch R, et al
    Pericardial effusion requiring surgical intervention after stem cell transplantation: a case series.
    Bone Marrow Transplant. 2016 Dec 19. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  49. MEISSNER J, Finel H, Dietrich S, Boumendil A, et al
    Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience.
    Bone Marrow Transplant. 2016 Dec 19. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  50. WILLEMSE SB, Bezuur DL, Blom P, Kneppers E, et al
    Hepatitis E virus infection and hepatic GvHD in allogeneic hematopoietic stem cell transplantation recipients.
    Bone Marrow Transplant. 2016 Dec 19. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  51. BUCCISANO F, Maurillo L, Piciocchi A, Del Principe MI, et al
    Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia.
    Bone Marrow Transplant. 2016 Dec 12. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  52. GHAZIKHANIAN SE, Dorfman CS, Somers TJ, O'Sullivan ML, et al
    Cognitive problems following hematopoietic stem cell transplant: relationships with sleep, depression and fatigue.
    Bone Marrow Transplant. 2016 Dec 12. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  53. FUJI S, Loffler J, Savani BN, Einsele H, et al
    Hyperglycemia as a possible risk factor for mold infections-the potential preventative role of intensified glucose control in allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 Dec 12. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  54. KORNBLIT B, Muller K
    Sensing danger: toll-like receptors and outcome in allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 Dec 12. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  55. POURHASSAN H, DeFor T, Trottier B, Dolan M, et al
    MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes.
    Bone Marrow Transplant. 2016 Dec 12. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  56. LEGRAND F, Le Floch AC, Granata A, Furst S, et al
    Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation for high-risk AML.
    Bone Marrow Transplant. 2016 Dec 12. doi: 10.1038/bmt.2016.
    PubMed     Text format    


    November 2016
  57. ALBRING JC, Inselmann S, Sauer T, Schliemann C, et al
    PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2016 Nov 28. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  58. MACHIDA S, Onizuka M, Toyosaki M, Aoyama Y, et al
    Danaparoid reduces the incidence of hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
    Bone Marrow Transplant. 2016 Nov 28. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  59. GHEZ D, Fortpied C, Mounier N, Carde P, et al
    First-line escalated BEACOPP does not hinder stem cell collection and transplantation strategy in patients with relapsed/refractory Hodgkin's lymphoma.
    Bone Marrow Transplant. 2016 Nov 28. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  60. AL JEFRI AH, Abujazar H, Al-Ahmari A, Al Rawas A, et al
    Veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic stem cell transplantation: Middle East/North Africa regional consensus on prevention, diagnosis and management.
    Bone Marrow Transplant. 2016 Nov 28. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  61. ROBINSON SP
    Diffuse large B-cell lymphoma: the challenge of relapse after an autologous stem cell transplant.
    Bone Marrow Transplant. 2016 Nov 21. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  62. ALSULTAN A, Essa M, Alsudairy R
    Hematopoietic stem cell transplantation in FANCJ/BRIP1 fanconi anemia.
    Bone Marrow Transplant. 2016 Nov 21. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  63. FERNANDEZ DE LARREA C, Davila J, Isola I, Ocio EM, et al
    Absence of spontaneous response improvement beyond day +100 after autologous stem cell transplantation in multiple myeloma.
    Bone Marrow Transplant. 2016 Nov 21. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  64. FIFE BL, Von Ah DM, Spath ML, Weaver MT, et al
    Preliminary efficacy of a brief family intervention to prevent declining quality of life secondary to parental bone marrow transplantation.
    Bone Marrow Transplant. 2016 Nov 21. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  65. GRESCH B, Kirsch M, Fierz K, Halter JP, et al
    Medication nonadherence to immunosuppressants after adult allogeneic haematopoietic stem cell transplantation: a multicentre cross-sectional study.
    Bone Marrow Transplant. 2016 Nov 14. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  66. WEDRYCHOWICZ A, Wojtys J, Starzyk J
    Anti-Muellerian hormone (AMH) as only possible marker in the assessment of ovarian function and reserve after hematopoietic stem cell transplantation (HSCT) in prepubertal girls, young females with composed hypogonadism and females receiving hormonal
    Bone Marrow Transplant. 2016 Nov 14. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  67. ISSARAGRISIL S, Cheng-Hwai T, Bunworasate U, Su-Peng Y, et al
    Cyclophosphamide vs salvage chemotherapy plus G-CSF as chemo-mobilization in Asian patients undergoing autologous hematopoietic stem cell transplant.
    Bone Marrow Transplant. 2016 Nov 14. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  68. LEE MH, Jang JH, Min HJ, Jang HI, et al
    Predictors of general discomfort, limitations in activities of daily living and intention of a second donation in unrelated hematopoietic stem cell donation.
    Bone Marrow Transplant. 2016 Nov 7. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  69. ROBIN M, Porcher R, Zinke-Cerwenka W, van Biezen A, et al
    Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT.
    Bone Marrow Transplant. 2016;.
    PubMed     Text format     Abstract available


  70. PASSWEG JR, Baldomero H, Bader P, Bonini C, et al
    Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT).
    Bone Marrow Transplant. 2016 Nov 7. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  71. SUGITA J, Miyamoto T, Kawashima N, Hatsumi N, et al
    Prior history of HLA-mismatched stem cell transplantation is a risk factor for graft failure in HLA-haploidentical transplantation.
    Bone Marrow Transplant. 2016 Nov 7. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  72. KHARFAN-DABAJA MA, Parody R, Perkins J, Lopez-Godino O, et al
    Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2016 Nov 7. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


    October 2016
  73. BIAN Z, Liu J, Xu LP, Chang YJ, et al
    Association of Epstein-Barr virus reactivation with the recovery of CD4/CD8 double-negative T lymphocytes after haploidentical hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 Oct 31. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  74. MA YR, Xu LP, Zhang XH, Yan CH, et al
    Comparable post-relapse outcomes between haploidentical and matched related donor allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2016 Oct 31. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  75. LI Z, Wang Y, Wang J, Zhang J, et al
    Successful haploidentical stem cell transplantation for three adults with primary hemophagocytic lymphohistiocytosis.
    Bone Marrow Transplant. 2016 Oct 24. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  76. BEN ABDEJLIL N, Belloumi D, Maammar M, El Fatimi R, et al
    Peripheral blood stem cell mobilization in multiple myeloma comparison of two consecutive regimens in a limited resources country.
    Bone Marrow Transplant. 2016 Oct 24. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  77. GAUTHIER J, Holmberg L, Wu D, Bensinger W, et al
    Minimal detectable disease confirmed by flow cytometry and poor outcome after autologous stem cell transplantation in peripheral T-Cell lymphomas.
    Bone Marrow Transplant. 2016 Oct 24. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  78. CASTAGNA L, Sarina B, Crocchiolo R, Bramanti S, et al
    Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2016 Oct 17. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  79. ROSENGREN S, Mellqvist UH, Nahi H, Forsberg K, et al
    Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994-2009.
    Bone Marrow Transplant. 2016 Oct 3. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


    September 2016
  80. CHOI YB, Yi ES, Lee JW, Sung KW, et al
    Immunosuppressive therapy versus alternative donor hematopoietic stem cell transplantation for children with severe aplastic anemia who lack an HLA-matched familial donor.
    Bone Marrow Transplant. 2016 Sep 26. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  81. FORCINA A, Baldan R, Marasco V, Cichero P, et al
    Control of infectious mortality due to carbapenemase-producing Klebsiella pneumoniae in hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 Sep 26. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  82. BAI L, Peters L, Xia W, Best G, et al
    Assessing pilot vial material as a surrogate for functional and phenotypic stem cell markers in cryopreserved haematopoietic stem cell product.
    Bone Marrow Transplant. 2016 Sep 26. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  83. SARACENI F, Bruno B, Lemoli RM, Meloni G, et al
    Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission.
    Bone Marrow Transplant. 2016 Sep 26. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  84. VAN DEN NESTE E, Schmitz N, Mounier N, Gill D, et al
    Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study.
    Bone Marrow Transplant. 2016 Sep 19. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  85. CAOCCI G, Vacca A, Piras E, Serreli V, et al
    Return to normal life after hematopoietic stem cell transplantation for thalassemia: a study of patients transplanted from matched sibling donors.
    Bone Marrow Transplant. 2016 Sep 19. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  86. GATTI-MAYS ME, Manion M, Bowen LN, Brown GT, et al
    Toxoplasmosis encephalitis with immune-reconstitution inflammatory syndrome in an allogeneic stem cell transplant patient: a case report.
    Bone Marrow Transplant. 2016 Sep 19. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  87. STRAATHOF K, Anoop P, Allwood Z, Silva J, et al
    Long-term outcome following cyclosporine-related neurotoxicity in paediatric allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 Sep 19. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  88. WILLASCH AM, Salzmann-Manrique E, Krenn T, Duerken M, et al
    Treatment of relapse after allogeneic stem cell transplantation in children and adolescents with ALL: the Frankfurt experience.
    Bone Marrow Transplant. 2016 Sep 19. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  89. HUSSEIN AA, Hamidieh AA, Elhaddad A, Ramzi M, et al
    First report of pediatric hematopoietic stem cell transplantation activities in the eastern mediterranean region from 1984 to 2011: on behalf of the pediatric cancer working committee of the eastern mediterranean blood and marrow transplantation group
    Bone Marrow Transplant. 2016 Sep 12. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  90. PHILLIPS EH, Hodson A, Hermine O, Bazarbachi A, et al
    Striving to cure adult T-cell leukaemia/lymphoma: a role for allogeneic stem cell transplant?
    Bone Marrow Transplant. 2016 Sep 12. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  91. BRAMMER JE, Saliba RM, Jorgensen JL, Ledesma C, et al
    Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomes.
    Bone Marrow Transplant. 2016 Sep 12. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  92. SIRVENT A, Auquier P, Oudin C, Bertrand Y, et al
    Prevalence and risk factors of iron overload after hematopoietic stem cell transplantation for childhood acute leukemia: a LEA study.
    Bone Marrow Transplant. 2016 Sep 5. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  93. KIM M, Park J, Lee J, Jang W, et al
    Hemolytic anemia with null PKLR mutations identified using whole exome sequencing and cured by hematopoietic stem cell transplantation combined with splenectomy.
    Bone Marrow Transplant. 2016 Sep 5. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  94. RAMASWAMI R, Pria AD, Parker K, McCann S, et al
    Outcomes of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory HIV-associated lymphoma.
    Bone Marrow Transplant. 2016 Sep 5. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  95. GARCIA-CADENAS I, Rivera I, Martino R, Esquirol A, et al
    Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease.
    Bone Marrow Transplant. 2016 Sep 5. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


    August 2016
  96. DEL PAPA N, Onida F, Zaccara E, Saporiti G, et al
    Autologous hematopoietic stem cell transplantation has better outcomes than conventional therapies in patients with rapidly progressive systemic sclerosis.
    Bone Marrow Transplant. 2016 Aug 22. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  97. GOMEZ-ALMAGUER D, Vazquez-Mellado A, Navarro-Cabrera JR, Abello-Polo V, et al
    The Latin American experience of allografting patients with severe aplastic anaemia: real-world data on the impact of stem cell source and ATG administration in HLA-identical sibling transplants.
    Bone Marrow Transplant. 2016 Aug 22. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  98. KOYAMA D, Ito M, Yokohata E, Watakabe K, et al
    Autoimmune-like hepatitis after allogeneic hematopoietic stem cell transplantation: humoral hepatic GvHD.
    Bone Marrow Transplant. 2016 Aug 15. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  99. MARCHESI F, Tendas A, Giannarelli D, Viggiani C, et al
    Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized study.
    Bone Marrow Transplant. 2016 Aug 15. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  100. O'DONNELL PV, Eapen M, Horowitz MM, Logan BR, et al
    Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis.
    Bone Marrow Transplant. 2016 Aug 15. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  101. WHANGBO J, Ritz J, Bhatt A
    Antibiotic-mediated modification of the intestinal microbiome in allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 Aug 15. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  102. ABOUL NOUR H, Patil N, Chewning JH, Di Stasi A, et al
    Safety of repeated un-manipulated peripheral blood stem cell haploidentical transplant for graft failure.
    Bone Marrow Transplant. 2016 Aug 15. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  103. ANDERLINI P
    Sixty as the new forty: considerations on older related stem cell donors.
    Bone Marrow Transplant. 2016 Aug 8. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  104. CHO WK, Ahn MB, Lee JW, Chung NG, et al
    Low bone mineral density in adolescents with leukemia after hematopoietic stem cell transplantation: prolonged steroid therapy for GvHD and endocrinopathy after hematopoietic stem cell transplantation might be major concerns?
    Bone Marrow Transplant. 2016 Aug 1. doi: 10.1038/bmt.2016.
    PubMed     Text format    


    July 2016
  105. CAGDAS D, Erman B, Hanoglu D, Tavil B, et al
    Course of IL-2-inducible T-cell kinase deficiency in a family: lymphomatoid granulomatosis, lymphoma and allogeneic bone marrow transplantation in one sibling; and death in the other.
    Bone Marrow Transplant. 2016 Jul 25. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  106. DEFILIPP Z, Rosand CB, Goldstein DA, Master VA, et al
    Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumors.
    Bone Marrow Transplant. 2016 Jul 18. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  107. MAGENAU J, Westervelt P, Khaled S, McGuirk J, et al
    A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 Jul 18. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  108. RIMONDO A, Crocchiolo R, El-Cheikh J, Bramanti S, et al
    The calcineurin inhibitor and the intensity of the conditioning regimen may affect the occurrence of polyomavirus-associated hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2016 Jul 18. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  109. EHRLICH KB, Miller GE, Scheide T, Baveja S, et al
    Pre-transplant emotional support is associated with longer survival after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 Jul 18. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  110. ZAMPAOLO AS, Kanold J, Tournilhac O, Franck F, et al
    Aggressive skin cancers in patients who experienced chronic GvHD after allogeneic bone marrow transplantation.
    Bone Marrow Transplant. 2016 Jul 18. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  111. GUTMAN JA, Ross K, Smith C, Myint H, et al
    Chronic graft versus host disease burden and late transplant complications are lower following adult double cord blood versus matched unrelated donor peripheral blood transplantation.
    Bone Marrow Transplant. 2016 Jul 11. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  112. SAKAGUCHI H, Matsumoto K, Yoshida N, Narita K, et al
    Dexamethasone palmitate for patients with engraftment syndrome is associated with favorable outcome for children with hematological malignancy.
    Bone Marrow Transplant. 2016 Jul 4. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  113. VAN VEEN KE, Brouwer MC, van der Ende A, van de Beek D, et al
    Bacterial meningitis in hematopoietic stem cell transplant recipients: a population-based prospective study.
    Bone Marrow Transplant. 2016 Jul 4. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  114. ESPIGADO I, Ortega-Ortega M, Montero-Granados R, Rodriguez-Torres N, et al
    Differences in stem cell transplantation activity among regions in Spain: an economic explanation.
    Bone Marrow Transplant. 2016 Jul 4. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  115. GALE RP
    Thirty years of Bone Marrow Transplantation.
    Bone Marrow Transplant. 2016 Jul 4. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  116. MUCHTAR E, Dingli D, Kumar S, Buadi FK, et al
    Autologous stem cell transplant for multiple myeloma patients 70 years or older.
    Bone Marrow Transplant. 2016 Jul 4. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  117. DEURING G, Kiss A, Halter JP, Passweg JR, et al
    Cardiac autonomic functioning is impaired among allogeneic hematopoietic stem cell transplantation survivors: a controlled study.
    Bone Marrow Transplant. 2016 Jul 4. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  118. INAGAKI J, Kurauchi K, Fukano R, Noguchi M, et al
    Heterogeneous response to recombinant thrombomodulin by grade of sinusoidal obstructive syndrome after pediatric stem cell transplantation.
    Bone Marrow Transplant. 2016 Jul 4. doi: 10.1038/bmt.2016.
    PubMed     Text format    


    June 2016
  119. ZAMA D, Biagi E, Masetti R, Gasperini P, et al
    Gut microbiota and hematopoietic stem cell transplantation: where do we stand?
    Bone Marrow Transplant. 2016 Jun 27. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  120. SHIN SH, Jeon YW, Yoon JH, Yahng SA, et al
    Comparable outcomes between younger (40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioning.
    Bone Marrow Transplant. 2016 Jun 27. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  121. HUANG WR, Li HH, Gao CJ, Bo J, et al
    Haploidentical, unmanipulated G-CSF-primed peripheral blood stem cell transplantation for high-risk hematologic malignancies: an update.
    Bone Marrow Transplant. 2016 Jun 20. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  122. LONG H, Lu ZG, Song CY, Huang YX, et al
    Long-term outcomes of HLA-haploidentical stem cell transplantation based on an FBCA conditioning regimen compared with those of HLA-identical sibling stem cell transplantation for haematologic malignancies.
    Bone Marrow Transplant. 2016 Jun 20. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  123. MAJZNER R, Sandoval C, Dozor AJ, Jin Z, et al
    Pulmonary function after hematopoietic stem cell transplantation is significantly better in pediatric recipients following reduced toxicity compared with myeloablative conditioning.
    Bone Marrow Transplant. 2016 Jun 20. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  124. ELSAID MY, Capitini CM, Diamond CA, Porte M, et al
    Successful matched unrelated donor stem cell transplant in Hemoglobin Bart's disease.
    Bone Marrow Transplant. 2016 Jun 13. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  125. TSIRIGOTIS P, Byrne M, Schmid C, Baron F, et al
    Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT.
    Bone Marrow Transplant. 2016 Jun 13. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  126. LINK CS, Mies F, Scheele J, Kramer M, et al
    Long-term follow-up of patients with relapsed or refractory non-Hodgkin's lymphoma receiving allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2016 Jun 13. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  127. POHLEN M, Groth C, Sauer T, Gorlich D, et al
    Outcome of allogeneic stem cell transplantation for AML and myelodysplastic syndrome in elderly patients (60 years).
    Bone Marrow Transplant. 2016 Jun 13. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  128. HORN B, O'Kane S, Wattier RL, Wahlstrom JT, et al
    Risk of serious bloodstream infections is low in pediatric hematopoietic stem cell transplant (HSCT) recipients with fevers due to antithymocyte globulins and alemtuzumab.
    Bone Marrow Transplant. 2016 Jun 6. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  129. DUFORT G, Castillo L, Pisano S, Castiglioni M, et al
    Haploidentical hematopoietic stem cell transplantation in children with high-risk hematologic malignancies: outcomes with two different strategies for GvHD prevention. Ex vivo T-cell depletion and post-transplant cyclophosphamide: 10 years of experien
    Bone Marrow Transplant. 2016 Jun 6. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  130. ROTENSTEIN L, Nathan A, Ghobrial I, Antin J, et al
    Management of refractory autoimmune hemolytic anemia via allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2016 Jun 6. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  131. AHMED SS, Wang XN, Norden J, Pearce K, et al
    Identification and validation of biomarkers associated with acute and chronic graft versus host disease.
    Bone Marrow Transplant. 2016;51:890.
    PubMed     Text format    


  132. OLIVEIRA MC, Labopin M, Henes J, Moore J, et al
    Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?
    Bone Marrow Transplant. 2016;51:889.
    PubMed     Text format    


    May 2016
  133. LEE SE, Yahng SA, Cho BS, Eom KS, et al
    Impact of pretransplant red cell transfusion on outcome after allogeneic stem cell transplantation in adult patients with severe aplastic anemia.
    Bone Marrow Transplant. 2016 May 23. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  134. GIFFORD G, Gilroy N, Dyer G, Brice L, et al
    The experience of survival following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia.
    Bone Marrow Transplant. 2016 May 23. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  135. KRUGER P, Cooney J, Nivison-Smith I, Dodds A, et al
    All is not lost in accelerated phase/blast crisis and after tyrosine kinase inhibitors fail in chronic myeloid leukaemia: a retrospective study of allogeneic stem cell transplant outcomes in Australia and New Zealand.
    Bone Marrow Transplant. 2016 May 23. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  136. PETRUSKEVICIUS I, Ludvigsen M, Hjortebjerg R, Sorensen BS, et al
    Clinical relevance of galectin-1 in hematologic malignancies treated with non-myeloablative hemopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 May 23. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  137. CHRISTOPEIT M, Badbaran A, Zabelina T, Zeck G, et al
    Similar outcome of calreticulin type I and calreticulin type II mutations following RIC allogeneic haematopoietic stem cell transplantation for myelofibrosis.
    Bone Marrow Transplant. 2016 May 23. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  138. JENQ RR, van den Brink MR
    Antibiotic prophylaxis in allogeneic stem cell transplantation-what is the correct choice?
    Bone Marrow Transplant. 2016 May 23. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  139. CURI DA, Duerst RE, Badke C, Bell J, et al
    IV pentamidine for Pneumocystis jiroveci pneumonia prophylaxis in pediatric allogeneic stem cell transplant patients.
    Bone Marrow Transplant. 2016 May 23. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  140. KOTHARI J, Foley M, Peggs KS, Mackenzie S, et al
    A retrospective comparison of toxicity and initial efficacy of two autologous stem cell transplant conditioning regimens for relapsed lymphoma: LEAM and BEAM.
    Bone Marrow Transplant. 2016 May 23. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  141. AKI SZ, Inamoto Y, Carpenter PA, Storer BE, et al
    Confounding factors affecting the National Institutes of Health (NIH) chronic Graft-Versus-Host Disease Organ-Specific Score and global severity.
    Bone Marrow Transplant. 2016 May 23. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  142. GORGENS A, Murke F, Kordelas L, Giebel B, et al
    Lost in Transplantation? Unexpected shift from multipotent to late lymphomyeloid hematopoietic stem and progenitor cells in patients 1 year after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 May 23. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  143. GREEN DJ, Bensinger WI, Holmberg LA, Gooley T, et al
    Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma.
    Bone Marrow Transplant. 2016 May 23. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  144. TSIRIGOTIS P, Danylesko I, Gkirkas K, Shem-Tov N, et al
    Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2016 May 16. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  145. LAM W, Viswabandya A, Hussain S, Messner HA, et al
    A unique case of tuberculosis dissemination presenting as cutaneous lesions in a post allogeneic stem cell transplant patient.
    Bone Marrow Transplant. 2016 May 16. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  146. LEE SY, Meehan RS, Seldin DC, Sloan JM, et al
    Effect of severe hypoalbuminemia on toxicity of high-dose melphalan and autologous stem cell transplantation in patients with AL amyloidosis.
    Bone Marrow Transplant. 2016 May 16. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  147. EL-BIETAR J, Nelson A, Wallace G, Dandoy C, et al
    RSV infection without ribavirin treatment in pediatric hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 May 16. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  148. OLIVER N, Luong T, Tchakarov A, Abdelrahim M, et al
    Disseminated cryptococcal infection in allogeneic stem cell transplant patients: a rare cause of acute kidney injury.
    Bone Marrow Transplant. 2016 May 9. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  149. BEIER R, Sykora KW, Woessmann W, Maecker-Kolhoff B, et al
    Allogeneic-matched sibling stem cell transplantation in a 13-year-old boy with ataxia telangiectasia and EBV-positive non-Hodgkin lymphoma.
    Bone Marrow Transplant. 2016 May 9. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  150. DESAI AV, Heneghan MB, Li Y, Bunin NJ, et al
    Toxicities of busulfan/melphalan versus carboplatin/etoposide/melphalan for high-dose chemotherapy with stem cell rescue for high-risk neuroblastoma.
    Bone Marrow Transplant. 2016 May 9. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  151. RASHIDI A, DiPersio JF, Westervelt P, Abboud CN, et al
    HLA disparity is not inconsequential in peripheral blood T-replete haploidentical hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 May 9. doi: 10.1038/bmt.2016.
    PubMed     Text format    


    April 2016
  152. GRECO R, Barbanti MC, Lupo Stranghellini MT, Giglio F, et al
    Coadministration of posaconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2016 Apr 25. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  153. TESSOULIN B, Ceballos P, Chevallier P, Blaise D, et al
    Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC.
    Bone Marrow Transplant. 2016 Apr 25. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  154. DOURTHE ME, Ternes N, Gajda D, Paci A, et al
    Busulfan-Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: an exposed-unexposed study evaluating the clinical impact of the order of drug administration.
    Bone Marrow Transplant. 2016 Apr 25. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  155. KOENECKE C, Heim D, van Biezen A, Heuser M, et al
    Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party.
    Bone Marrow Transplant. 2016 Apr 25. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  156. RIWES MM, Leather H, Neal D, Bennett C, et al
    Association of mannose-binding lectin levels and invasive fungal disease in hematologic malignancy patients receiving myelosuppressive chemotherapy or allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 Apr 18. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  157. HOCHBERG J, Harrison L, Morris E, Militano O, et al
    Safety of liposomal cytarabine CNS prophylaxis in children, adolescent and young adult hematopoietic stem cell transplant recipients with acute leukemia and non-Hodgkin lymphoma.
    Bone Marrow Transplant. 2016 Apr 18. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  158. ALCHALBY H, Yunus DR, Zabelina T, Ayuk F, et al
    Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis.
    Bone Marrow Transplant. 2016 Apr 18. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  159. MARTINO M, Tripepi G, Messina G, Vincelli ID, et al
    A phase II, single-arm, prospective study of bendamustine plus melphalan conditioning for second autologous stem cell transplantation in de novo multiple myeloma patients through a tandem transplant strategy.
    Bone Marrow Transplant. 2016 Apr 18. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  160. CLARK CA, Savani M, Mohty M, Savani BN, et al
    What do we need to know about allogeneic hematopoietic stem cell transplant survivors?
    Bone Marrow Transplant. 2016 Apr 11. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  161. GONSALVES WI, Rajkumar SV, Gertz MA, Dispenzieri A, et al
    Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy.
    Bone Marrow Transplant. 2016 Apr 11. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  162. HE X, Wang Q, Cen J, Qiu H, et al
    Predictive value of high EVI1 expression in AML patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation in first CR.
    Bone Marrow Transplant. 2016 Apr 4. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  163. RAMANATHAN M, Teira P, Battiwalla M, Barrett J, et al
    Impact of early CMV reactivation in cord blood stem cell recipients in the current era.
    Bone Marrow Transplant. 2016 Apr 4. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  164. DESJONQUERES A, Illiaquer M, Duquesne A, Le Bris Y, et al
    Longer delay of hematological recovery and increased transfusion needs after haploidentical compared to non-haploidentical stem cell transplantation.
    Bone Marrow Transplant. 2016 Apr 4. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  165. MICHEL L, Farge D, Baraut J, Marjanovic Z, et al
    Evolution of serum cytokine profile after hematopoietic stem cell transplantation in systemic sclerosis patients.
    Bone Marrow Transplant. 2016 Apr 4. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  166. ANANDI P, Jain NA, Tian X, Wu CO, et al
    Factors influencing the late phase of recovery after bone mineral density loss in allogeneic stem cell transplantation survivors.
    Bone Marrow Transplant. 2016 Apr 4. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  167. STAMATOULLAS A, Brice P, Gueye MS, Mareschal S, et al
    Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin's lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC).
    Bone Marrow Transplant. 2016 Apr 4. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  168. MARTINO M, Lemoli RM, Girmenia C, Castagna L, et al
    Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma.
    Bone Marrow Transplant. 2016 Apr 4. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  169. WUILLEME S, Lok A, Robillard N, Dupuis P, et al
    Assessment of tumoral plasma cells in apheresis products for autologous stem cell transplantation in multiple myeloma.
    Bone Marrow Transplant. 2016 Apr 4. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  170. DMYTRUS J, Matthes-Martin S, Pichler H, Worel N, et al
    Multi-color immune-phenotyping of CD34 subsets reveals unexpected differences between various stem cell sources.
    Bone Marrow Transplant. 2016 Apr 4. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  171. BOUDIN L, Goncalves A, Sabatier R, Moretta J, et al
    Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 Apr 4. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  172. SAILLARD C, Blaise D, Mokart D
    Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosis.
    Bone Marrow Transplant. 2016 Apr 4. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  173. PIETZNER J, Merscher BM, Baer PC, Duecker RP, et al
    Low-dose irradiation prior to bone marrow transplantation results in ATM activation and increased lethality in Atm-deficient mice.
    Bone Marrow Transplant. 2016;51:619.
    PubMed     Text format    


    March 2016
  174. EL-JAWAHRI A, Kim HT, Steensma DP, Cronin AM, et al
    Does quality of life impact the decision to pursue stem cell transplantation for elderly patients with advanced MDS?
    Bone Marrow Transplant. 2016 Mar 21. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  175. WEBER D, Oefner PJ, Dettmer K, Hiergeist A, et al
    Rifaximin preserves intestinal microbiota balance in patients undergoing allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2016 Mar 21. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  176. ANUR P, Friedman DN, Sklar C, Oeffinger K, et al
    Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors.
    Bone Marrow Transplant. 2016 Mar 21. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  177. ANDO M
    The need for 'onco-nephrology' is increasing in hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 Mar 21. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  178. TAKEKIYO T, Dozono K, Mitsuishi T, Nara S, et al
    Recovery of physical function and quality of life in patients undergoing hematopoietic stem cell transplantation: a 1-year follow-up.
    Bone Marrow Transplant. 2016 Mar 21. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  179. MYERS KC, Howell JC, Wallace G, Dandoy C, et al
    Poor growth, thyroid dysfunction and vitamin D deficiency remain prevalent despite reduced intensity chemotherapy for hematopoietic stem cell transplantation in children and young adults.
    Bone Marrow Transplant. 2016 Mar 14. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  180. HOBBS GS, Kaur N, Hilden P, Ponce D, et al
    A novel reduced intensity conditioning regimen for patients with high-risk hematological malignancies undergoing allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2016 Mar 14. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  181. MAZZA P, Palazzo G, Minoia C, Amurri B, et al
    Autologous and allogeneic stem cell transplant in Jehovah's Witnesses: a single-center experience on 22 patients.
    Bone Marrow Transplant. 2016 Mar 7. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  182. ALLAREDDY V, Rampa S, Martinez-Schlurmann N, Nalliah RP, et al
    Regionalization of stem cell transplant procedures into teaching hospitals in United States: are we ready?
    Bone Marrow Transplant. 2016 Mar 7. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  183. VARMA A, Saliba RM, Torres HA, Afrough A, et al
    Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation.
    Bone Marrow Transplant. 2016 Mar 7. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  184. SAYAN M, Cassidy RJ, Butker EE, Nanda RH, et al
    Gonadal shielding technique to preserve fertility in male pediatric patients treated with total body irradiation for stem cell transplantation.
    Bone Marrow Transplant. 2016 Mar 7. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  185. BEAUVERD Y, Roosnek E, Tirefort Y, Dantin C, et al
    Outcome of hematopoietic stem cell transplantation is similar for patients with a partial in vitro T-cell-depleted graft compared with a non-T-cell-depleted graft when stratified by the refined disease risk index.
    Bone Marrow Transplant. 2016 Mar 7. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


    February 2016
  186. MAYO S, Messner HA, Rourke SB, Howell D, et al
    Relationship between neurocognitive functioning and medication management ability over the first 6 months following allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2016 Feb 29. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  187. PASSWEG JR, Baldomero H, Bader P, Bonini C, et al
    Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually.
    Bone Marrow Transplant. 2016 Feb 22. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  188. ARITA K, Murakami J, Wada A, Miyazono T, et al
    Changes in the autoantibody pattern during allogeneic stem-cell transplantation for acute myeloid leukemia complicated by systemic lupus erythematosus.
    Bone Marrow Transplant. 2016 Feb 22. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  189. ARAI A, Sakashita C, Hirose C, Imadome KI, et al
    Hematopoietic stem cell transplantation for adults with EBV-positive T- or NK-cell lymphoproliferative disorders: efficacy and predictive markers.
    Bone Marrow Transplant. 2016 Feb 22. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  190. NIEDERWIESER D, Baldomero H, Szer J, Gratwohl M, et al
    Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey.
    Bone Marrow Transplant. 2016 Feb 22. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  191. BADBARAN A, Fehse B, Christopeit M, Aranyossy T, et al
    Digital-PCR assay for screening and quantitative monitoring of calreticulin (CALR) type-2 positive patients with myelofibrosis following allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2016 Feb 15. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  192. ISHIYAMA K, Takeda J, Kondo T, Sugimoto N, et al
    Feasibility of salvage cord blood transplantation following fludarabine, melphalan and low-dose TBI for graft rejection after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 Feb 15. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  193. NOERSKOV KH, Schjodt I, Syrjala KL, Jarden M, et al
    Sexual function 1-year after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 Feb 15. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  194. ANURATHAPAN U, Hongeng S, Pakakasama S, Sirachainan N, et al
    Hematopoietic stem cell transplantation for homozygous beta-thalassemia and beta-thalassemia/hemoglobin E patients from haploidentical donors.
    Bone Marrow Transplant. 2016 Feb 15. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  195. GUAN P, Bassiri H, Patel NP, Nichols KE, et al
    Invariant natural killer T cells in hematopoietic stem cell transplantation: killer choice for natural suppression.
    Bone Marrow Transplant. 2016 Feb 15. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  196. CLUZEAU T, Lambert J, Raus N, Dessaux K, et al
    Risk factors and outcome of graft failure after HLA matched and mismatched unrelated donor hematopoietic stem cell transplantation: a study on behalf of SFGM-TC and SFHI.
    Bone Marrow Transplant. 2016 Feb 8. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  197. MASOURIDI-LEVRAT S, Simonetta F, Beauverd Y, Tsopra O, et al
    Excellent outcome with a high proportion of mixed chimerism in patients with severe aplastic anemia treated with partially T-cell-depleted peripheral hematopoietic stem cell transplants.
    Bone Marrow Transplant. 2016 Feb 8. doi: 10.1038/bmt.2015.
    PubMed     Text format    


  198. LIM SH, Hyun SH, Kim HS, Lee JY, et al
    Prognostic relevance of pretransplant Deauville score on PET-CT and presence of EBV DNA in patients who underwent autologous stem cell transplantation for ENKTL.
    Bone Marrow Transplant. 2016 Feb 8. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available


  199. SARMIENTO M, Parody R, Marquez-Malaver F, Espigado I, et al
    Pre-transplant diastolic but not systolic dysfunction has a negative prognostic impact after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2016 Feb 8. doi: 10.1038/bmt.2016.
    PubMed     Text format    


  200. YARED JA, Hardy N, Singh Z, Hajj S, et al
    Major clinical response to nivolumab in relapsed/refractory Hodgkin lymphoma after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2016 Feb 1. doi: 10.1038/bmt.2015.
    PubMed     Text format    


    January 2016
  201. VAN DER DOEF HP, Bathoorn E, van der Linden MP, Wolfs TF, et al
    Astrovirus outbreak at a pediatric hematology and hematopoietic stem cell transplant unit despite strict hygiene rules.
    Bone Marrow Transplant. 2016 Jan 25. doi: 10.1038/bmt.2015.
    PubMed     Text format    


  202. BROWN M, Myers D, Shreve N, Rahmetullah R, et al
    Reduced intensity conditioning regimen with fludarabine, cyclophosphamide, low dose TBI and alemtuzumab leading to successful unrelated umbilical cord stem cell engraftment and survival in two children with dyskeratosis congenita.
    Bone Marrow Transplant. 2016 Jan 25. doi: 10.1038/bmt.2015.
    PubMed     Text format    


  203. BHATTACHARYYA R, Tan AM, Chan MY, Jamuar SS, et al
    TCR alphabeta and CD19-depleted haploidentical stem cell transplant with reduced intensity conditioning for Hoyeraal-Hreidarsson syndrome with RTEL1 mutation.
    Bone Marrow Transplant. 2016 Jan 25. doi: 10.1038/bmt.2015.
    PubMed     Text format    


  204. TRUONG TH, Moorjani R, Dewey D, Guilcher GM, et al
    Adverse reactions during stem cell infusion in children treated with autologous and allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2016 Jan 11. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  205. PAWLOWSKA M, Yang Q, Hamata B, Kendler DL, et al
    Early changes in bone mineral density and trabecular bone score following allogeneic stem cell transplant.
    Bone Marrow Transplant. 2016 Jan 11. doi: 10.1038/bmt.2015.
    PubMed     Text format    


  206. LIANG CS, Quesada AE, Goswami M, Johnston PK, et al
    Phosphorylated STAT3 expression in hematopoietic stem cell transplant-associated large granular lymphocytic leukemia.
    Bone Marrow Transplant. 2016 Jan 11. doi: 10.1038/bmt.2015.
    PubMed     Text format    


  207. TENDAS A, Cupelli L, Mauroni MR, Sollazzo F, et al
    Rehabilitation need and referrals in hematopoietic stem cell transplantation: the experience of Quality of Life Working Party of the Rome Transplant Network.
    Bone Marrow Transplant. 2016 Jan 11. doi: 10.1038/bmt.2015.
    PubMed     Text format    


  208. TANAKA Y, Kurosawa S, Tajima K, Tanaka T, et al
    Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2016 Jan 11. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  209. LINK CS, Teipel R, Heidenreich F, Rucker-Braun E, et al
    Durable responses to ibrutinib in patients with relapsed CLL after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2016 Jan 11. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  210. PIETZNER J, Merscher BM, Baer PC, Duecker RP, et al
    Low-dose irradiation prior to bone marrow transplantation results in ATM activation and increased lethality in Atm-deficient mice.
    Bone Marrow Transplant. 2016 Jan 11. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  211. BARONCIANI D, Angelucci E, Potschger U, Gaziev J, et al
    Hemopoietic stem cell transplantation in thalassemia: a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000-2010.
    Bone Marrow Transplant. 2016 Jan 11. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  212. SHANG J, Wang H, Sun J, Fan Z, et al
    A comparison of lamivudine vs entecavir for prophylaxis of hepatitis B virus reactivation in allogeneic hematopoietic stem cell transplantation recipients: a single-institutional experience.
    Bone Marrow Transplant. 2016 Jan 11. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  213. RASHIDI A, Ebadi M, Cashen AF
    Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma: a systematic review and meta-analysis.
    Bone Marrow Transplant. 2016 Jan 4. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  214. DHAKAL B, Vesole DH, Hari PN
    Allogeneic stem cell transplantation for multiple myeloma: is there a future?
    Bone Marrow Transplant. 2016 Jan 4. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  215. AFIFI S, Adel NG, Devlin S, Duck E, et al
    Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: efficacy and cost analysis study.
    Bone Marrow Transplant. 2016 Jan 4. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  216. HANIF A, Hari PN, Atallah E, Carlson KS, et al
    Safety of ruxolitinib therapy prior to allogeneic hematopoietic stem-cell transplantation for myeloproliferative neoplasms.
    Bone Marrow Transplant. 2016 Jan 4. doi: 10.1038/bmt.2015.
    PubMed     Text format    


  217. DEL FANTE C, Galasso T, Bernasconi P, Scudeller L, et al
    Extracorporeal photopheresis as a new supportive therapy for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2016 Jan 4. doi: 10.1038/bmt.2015.
    PubMed     Text format    


  218. CAIRO MS, Tarek N, Lee DA, Delaney C, et al
    Cellular engineering and therapy in combination with cord blood allografting in pediatric recipients.
    Bone Marrow Transplant. 2016;51:27-33.
    PubMed     Text format     Abstract available


    December 2015
  219. CHATURVEDI S, Neff A, Nagler A, Savani U, et al
    Venous thromboembolism in hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2015 Dec 21. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  220. ANSARI M, Huezo-Diaz P, Rezgui MA, Marktel S, et al
    Influence of glutathione S-transferase gene polymorphisms on busulfan pharmacokinetics and outcome of hematopoietic stem-cell transplantation in thalassemia pediatric patients.
    Bone Marrow Transplant. 2015 Dec 21. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  221. GANETSKY A, Shah A, Miano TA, Hwang WT, et al
    Higher tacrolimus concentrations early after transplant reduce the risk of acute GvHD in reduced-intensity allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2015 Dec 21. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  222. VINER SMITH E, Tierney AC, Klarica D, Walker P, et al
    Impact of a lifestyle modification program on the metabolic syndrome and associated risk factors in long-term survivors of stem cell transplantation.
    Bone Marrow Transplant. 2015 Dec 21. doi: 10.1038/bmt.2015.
    PubMed     Text format    


  223. YAN CH, Xu LP, Wang FR, Chen H, et al
    Causes of mortality after haploidentical hematopoietic stem cell transplantation and the comparison with HLA-identical sibling hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2015 Dec 21. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  224. KUSKONMAZ B, Ayvaz D, Aydemir Y, Erman B, et al
    Successful outcome with second hematopoietic stem cell transplantation in a patient with IL-10R deficiency.
    Bone Marrow Transplant. 2015 Dec 21. doi: 10.1038/bmt.2015.
    PubMed     Text format    


  225. AOKI J, Seo S, Kanamori H, Tanaka M, et al
    Impact of low-dose TBI on outcomes of reduced intensity conditioning allogeneic hematopoietic stem cell transplantation for AML.
    Bone Marrow Transplant. 2015 Dec 7. doi: 10.1038/bmt.2015.
    PubMed     Text format    


  226. SNARSKI E, Milczarczyk A, Halaburda K, Torosian T, et al
    Immunoablation and autologous hematopoietic stem cell transplantation in the treatment of new-onset type 1 diabetes mellitus: long-term observations.
    Bone Marrow Transplant. 2015 Dec 7. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  227. SOLANO C, Gimenez E, Pinana JL, Vinuesa V, et al
    Preemptive antiviral therapy for CMV infection in allogeneic stem cell transplant recipients guided by the viral doubling time in the blood.
    Bone Marrow Transplant. 2015 Dec 7. doi: 10.1038/bmt.2015.
    PubMed     Text format    


  228. BRISSOT E, Rialland F, Cahu X, Strullu M, et al
    Improvement of overall survival after allogeneic hematopoietic stem cell transplantation for children and adolescents: a three-decade experience of a single institution.
    Bone Marrow Transplant. 2015 Dec 7. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  229. OLIVEIRA MC, Labopin M, Henes J, Moore J, et al
    Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?
    Bone Marrow Transplant. 2015 Dec 7. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  230. XUE E, Tresoldi C, Sala E, Crippa A, et al
    Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse.
    Bone Marrow Transplant. 2015 Dec 7. doi: 10.1038/bmt.2015.
    PubMed     Text format    


    November 2015
  231. ROBINSON SP, Boumendil A, Finel H, Blaise D, et al
    Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working Party.
    Bone Marrow Transplant. 2015 Nov 30. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  232. CAHU X, Labopin M, Giebel S, Aljurf M, et al
    Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT.
    Bone Marrow Transplant. 2015 Nov 30. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  233. LE BOURGEOIS A, Malard F, Chevallier P, Urbistandoy G, et al
    Impact of pre-transplant diffusion lung capacity for nitric oxide (DLNO) and of DLNO/pre-transplant diffusion lung capacity for carbon monoxide (DLNO/DLCO) ratio on pulmonary outcomes in adults receiving allogeneic stem cell transplantation for hemato
    Bone Marrow Transplant. 2015 Nov 23. doi: 10.1038/bmt.2015.
    PubMed     Text format    


  234. YAKUSHIJIN K, Atsuta Y, Doki N, Yokota A, et al
    Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes.
    Bone Marrow Transplant. 2015 Nov 23. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  235. MAMEZ AC, Levy V, Chevallier P, Blaise D, et al
    Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC).
    Bone Marrow Transplant. 2015 Nov 23. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  236. VOLK V, Schneider A, Spineli LM, Grosshennig A, et al
    The gender gap: discrepant human T-cell reconstitution after cord blood stem cell transplantation in humanized female and male mice.
    Bone Marrow Transplant. 2015 Nov 23. doi: 10.1038/bmt.2015.
    PubMed     Text format    


  237. SHINOHARA A, Honda A, Nukina A, Takaoka K, et al
    Acute pericarditis before engraftment in hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2015 Nov 23. doi: 10.1038/bmt.2015.
    PubMed     Text format    


  238. HAMIDIEH AA, Behfar M, Pourpak Z, Faghihi-Kashani S, et al
    Long-term outcomes of fludarabine, melphalan and antithymocyte globulin as reduced-intensity conditioning regimen for allogeneic hematopoietic stem cell transplantation in children with primary immunodeficiency disorders: a prospective single center s
    Bone Marrow Transplant. 2015 Nov 23. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  239. MARTINEZ-CIBRIAN N, Magnano L, Gutierrez-Garcia G, Andrade X, et al
    At-home autologous stem cell transplantation in multiple myeloma with and without G-CSF administration: a comparative study.
    Bone Marrow Transplant. 2015 Nov 23. doi: 10.1038/bmt.2015.
    PubMed     Text format    


  240. SELLNER L, Boumendil A, Finel H, Choquet S, et al
    Thiotepa-based high-dose therapy for autologous stem cell transplantation in lymphoma: a retrospective study from the EBMT.
    Bone Marrow Transplant. 2015 Nov 16. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  241. PLATON L, Amigues L, Ceballos P, Fegueux N, et al
    A reappraisal of ICU and long-term outcome of allogeneic hematopoietic stem cell transplantation patients and reassessment of prognosis factors: results of a 5-year cohort study (2009-2013).
    Bone Marrow Transplant. 2015 Nov 16. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  242. ANGENENDT L, Schliemann C, Lutz M, Rebber E, et al
    Nivolumab in a patient with refractory Hodgkin's lymphoma after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2015 Nov 9. doi: 10.1038/bmt.2015.
    PubMed     Text format    


  243. RASHIDI A, DiPersio JF, Westervelt P, Abboud CN, et al
    Acute myeloid leukemia presenting with extensive bone marrow necrosis, leukemia cutis and testicular involvement: successful treatment with allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2015 Nov 9. doi: 10.1038/bmt.2015.
    PubMed     Text format    


  244. MASOURIDI-LEVRAT S, Pradier A, Simonetta F, Kaiser L, et al
    Torque teno virus in patients undergoing allogeneic hematopoietic stem cell transplantation for hematological malignancies.
    Bone Marrow Transplant. 2015 Nov 9. doi: 10.1038/bmt.2015.
    PubMed     Text format    


  245. MAINARDI C, Tumino M, Gazzola MV, Rampazzo A, et al
    TCRalphabeta CD19 depletion in allogeneic haematopoietic stem cell transplantation performed for Hurler syndrome.
    Bone Marrow Transplant. 2015 Nov 9. doi: 10.1038/bmt.2015.
    PubMed     Text format    


  246. HAJI S, Kiyasu J, Choi I, Suehiro Y, et al
    Administration of an anti-CC chemokine receptor 4 monoclonal antibody, mogamulizumab, before allogeneic bone marrow transplantation for adult T-cell leukemia/lymphoma.
    Bone Marrow Transplant. 2015 Nov 2. doi: 10.1038/bmt.2015.
    PubMed     Text format    


  247. PASQUALINI C, Dufour C, Goma G, Raquin MA, et al
    Tandem high-dose chemotherapy with thiotepa and busulfan-melphalan and autologous stem cell transplantation in very high-risk neuroblastoma patients.
    Bone Marrow Transplant. 2015 Nov 2. doi: 10.1038/bmt.2015.
    PubMed     Text format     Abstract available


  248. PILLAY B, Lee SJ, Katona L, De Bono S, et al
    Factors associated with post-traumatic stress symptoms experienced in the acute phase following haemopoietic stem cell transplant.
    Bone Marrow Transplant. 2015 Nov 2. doi: 10.1038/bmt.2015.
    PubMed     Text format    


    May 2015
  249. ANTHIAS C, van Walraven SM, Sorensen BS, de Faveri GN, et al
    Related hematopoietic cell donor care: is there a role for unrelated donor registries?
    Bone Marrow Transplant. 2015;50:637-41.
    PubMed     Text format     Abstract available


  250. TOLAR J, Sodani P, Symons H
    Alternative donor transplant of benign primary hematologic disorders.
    Bone Marrow Transplant. 2015;50:619-27.
    PubMed     Text format     Abstract available


    April 2015
  251. DHAKAL B, D'Souza A, Arce-Lara C, Pasquini M, et al
    Superior efficacy but higher cost of plerixafor and abbreviated-course G-CSF for mobilizing hematopoietic progenitor cells (HPC) in AL amyloidosis.
    Bone Marrow Transplant. 2015;50:610-2.
    PubMed     Text format    


  252. KIM MG, Han N, Lee EK, Kim T, et al
    Pegfilgrastim vs filgrastim in PBSC mobilization for autologous hematopoietic SCT: a systematic review and meta-analysis.
    Bone Marrow Transplant. 2015;50:523-30.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stem Cell Research is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: